alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › trials

trials

4 studies tagged trials, dated 2016-05-12 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials 2024-01-01
  2. The need to show minimum clinically important differences in Alzheimer's disease trials 2021-06-01
  3. Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov 2020-08-04

Studies

4 studies carry this tag.

Date range

2016 to 2024

Top journals

  • Alzheimer's research & therapy 1
  • JMIR mHealth and uHealth 1
  • The journal of prevention of Alzheimer's disease 1
  • The lancet. Psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. The journal of prevention of Alzheimer's disease 2024-01-01 Biomarkers

    Online registries, such as the Alzheimer's Prevention Trials (APT) Webstudy, include and follow participants using remote assessments to facilitate efficient screening and enrollment of large numbers of individuals who may be at higher risk for AD.

  2. The need to show minimum clinically important differences in Alzheimer's disease trials

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. The lancet. Psychiatry 2021-06-01 Treatments

    Deciding on the smallest change in an outcome that constitutes a clinically meaningful treatment effect (ie, the minimum clinically important difference [MCID]) is fundamental to interpreting clinical trial outcomes, making clinical decisions, and designing studies with sufficient statistical power to detect any such effect.

  3. Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. JMIR mHealth and uHealth 2020-08-04 Cognitive tests and assessment

    Despite the increasing use of health-based technologies, this analysis of ClinicalTrials.gov suggests that only a few apps for high-burden neuropsychiatric conditions are being clinically evaluated in trials.

  4. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials

    ✓ Peer-reviewed alzhub usefulness score 80 out of 100. Alzheimer's research & therapy 2016-05-12 Tau biomarkers

    These phase 3 global trials confirmed lack of efficacy of bapineuzumab at tested doses on clinical endpoints in patients with mild to moderate AD.

All topic tags with their study counts